Nplus1 Brewin restated their buy rating on shares of Oxford BioMedica plc (LON:OXB) in a report released on Wednesday, AnalystRatingsNetwork.com reports. Nplus1 Brewin currently has a GBX 3.57 ($0.06) price objective on the stock. Several other analysts have also recently commented on the stock. Analysts at N+1 Singer reiterated a buy rating on shares of […]
Oxford BioMedica plc Receives “Buy” Rating from Nplus1 Brewin (OXB) is a post from: Zolmax
The post Oxford BioMedica plc Receives “Buy” Rating from Nplus1 Brewin (OXB) appeared first on Zolmax.